Online Database of Chemicals from Around the World Search | Submit | Advertising

chemBlink >> Chemical Listing >> Bevasiranib>> Market Analysis Reports
 




Market Analysis Reports of Bevasiranib

Bevasiranib (CAS 959961-96-7) Market Research Report 2019
BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).

Global Market Report of Bevasiranib (CAS 959961-96-7)
October 2016

CAS 959961-96-7 Bevasiranib Chemical Report & Database
... listed. The substance covered (Bevasiranib) are classified by the Chemical ... Report & Database definitions: Name: Bevasiranib: Bevasiranib Chemical Registry number: 769198061655 ... : Chemical or Reaction Intermediate The Bevasiranib Report & Database gives Market ...

Delivering RNAi-Based Therapeutics & Diagnostics Challenges & Opportunities
... RNAi-based therapies, Opko Health’s bevasiranib and Allergan’s AGN-745, were ...

RNAi for Therapeutic Applications: Market Prospects 2011-2021
How will the RNA interference (RNAi) therapies market develop this decade? Our new report shows you that emerging market's revenue potential from 2011 to 2021. You will see the commercial prospects for RNAi-based therapeutics. We aim to save you time and ...

Opko Health, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
... develop pharmaceutical product candidates. Bevasiranib, a drug candidate in development for the ... steps regarding the development of bevasiranib. The company intends to continue ... inflammation and scarring. In addition to bevasiranib and its other siRNA ...

Ophthalmic Drugs: World Market Prospects 2013-2023
Report Details How to find trends and revenue predictions for the ophthalmic drug industry What are the commercial prospects for treating eye disorders? Visiongain's new report gives you forecasted revenues to 2023. It explains trends, opportunities and ...








Copyright ©  chemBlink. All rights reserved. Content Disclaimer | About chemBlink | Contact